Platinum-resistant Small Cell Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-04-13
Clinical Trial Update: Testing of Tazemetostat in Combination With Topotecan and Pembrolizumab in Patients With Recurrent Small Cell Lung Cancer [Phase 1]
This entry describes an ongoing Phase 1 clinical trial evaluating tazemetostat in combination with topotecan and pembrolizumab for recurrent…